Cargando…
Medication adherence among community-dwelling schizophrenia patients during the COVID-19 pandemic: A cross-sectional study
OBJECTIVES: This study aims to investigate medication adherence during the COVID-19 pandemic among community-dwelling schizophrenia patients, and to explore the role of social support in improving medication adherence in a rural community sample in China. METHODS: A cross-sectional sample of 800 pat...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461236/ https://www.ncbi.nlm.nih.gov/pubmed/36113253 http://dx.doi.org/10.1016/j.psychres.2022.114841 |
_version_ | 1784786931971784704 |
---|---|
author | Yao, Lansicheng Liu, Hongying Tian, Xiaobing |
author_facet | Yao, Lansicheng Liu, Hongying Tian, Xiaobing |
author_sort | Yao, Lansicheng |
collection | PubMed |
description | OBJECTIVES: This study aims to investigate medication adherence during the COVID-19 pandemic among community-dwelling schizophrenia patients, and to explore the role of social support in improving medication adherence in a rural community sample in China. METHODS: A cross-sectional sample of 800 patients was recruited using a cluster random sampling method in Yingshan County, Sichuan Province. Information on participant demographic characteristics, social support and medication adherence was collected through face-to-face interviews. The data analysis was performed using SAS9.4. Two binary logistic regression models were employed to identify the association between regular medication use and social support. RESULTS: The rate of regular medication adherence among community-dwelling patients with schizophrenia was 41.5%,which was lower than that indicated by recent research(Li et al., 2020) before COVID-19 in western rural China. The mean scores and standard deviation of the patient's objective support, subjective support, and support utilization were 4.94 ± 1.57, 17.03 ± 5.24, and 5.25 ± 2.75, respectively. The social support standard deviation was 27.22 ± 6.32. The crude odds ratio of objective support, subjective support, and support utilization were 0.790 (95%CI:0.713–0.876), 0.999 (95%CI:0.971–1.027), and 1.049 (95%CI:0.995–1.105) respectively. After adjusting for potential factors, the adjusted odds ratio of objective support, subjective support, and support utilization were 0.758 (95%CI:0.673–0.853), 1.030 (95%CI:0.994–1.068), and 1.043 (95%CI:0.985–1.105), respectively. CONCLUSIONS: During the COVID-19 pandemic, community-dwelling schizophrenia patients had a low rate of regular medication adherence. This was particularly true of those who were older adults, less educated and living in rural areas. The results of this study suggest that strengthening social support may effectively improve medication adherence for those patients. |
format | Online Article Text |
id | pubmed-9461236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94612362022-09-10 Medication adherence among community-dwelling schizophrenia patients during the COVID-19 pandemic: A cross-sectional study Yao, Lansicheng Liu, Hongying Tian, Xiaobing Psychiatry Res Article OBJECTIVES: This study aims to investigate medication adherence during the COVID-19 pandemic among community-dwelling schizophrenia patients, and to explore the role of social support in improving medication adherence in a rural community sample in China. METHODS: A cross-sectional sample of 800 patients was recruited using a cluster random sampling method in Yingshan County, Sichuan Province. Information on participant demographic characteristics, social support and medication adherence was collected through face-to-face interviews. The data analysis was performed using SAS9.4. Two binary logistic regression models were employed to identify the association between regular medication use and social support. RESULTS: The rate of regular medication adherence among community-dwelling patients with schizophrenia was 41.5%,which was lower than that indicated by recent research(Li et al., 2020) before COVID-19 in western rural China. The mean scores and standard deviation of the patient's objective support, subjective support, and support utilization were 4.94 ± 1.57, 17.03 ± 5.24, and 5.25 ± 2.75, respectively. The social support standard deviation was 27.22 ± 6.32. The crude odds ratio of objective support, subjective support, and support utilization were 0.790 (95%CI:0.713–0.876), 0.999 (95%CI:0.971–1.027), and 1.049 (95%CI:0.995–1.105) respectively. After adjusting for potential factors, the adjusted odds ratio of objective support, subjective support, and support utilization were 0.758 (95%CI:0.673–0.853), 1.030 (95%CI:0.994–1.068), and 1.043 (95%CI:0.985–1.105), respectively. CONCLUSIONS: During the COVID-19 pandemic, community-dwelling schizophrenia patients had a low rate of regular medication adherence. This was particularly true of those who were older adults, less educated and living in rural areas. The results of this study suggest that strengthening social support may effectively improve medication adherence for those patients. Elsevier B.V. 2022-11 2022-09-09 /pmc/articles/PMC9461236/ /pubmed/36113253 http://dx.doi.org/10.1016/j.psychres.2022.114841 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Yao, Lansicheng Liu, Hongying Tian, Xiaobing Medication adherence among community-dwelling schizophrenia patients during the COVID-19 pandemic: A cross-sectional study |
title | Medication adherence among community-dwelling schizophrenia patients during the COVID-19 pandemic: A cross-sectional study |
title_full | Medication adherence among community-dwelling schizophrenia patients during the COVID-19 pandemic: A cross-sectional study |
title_fullStr | Medication adherence among community-dwelling schizophrenia patients during the COVID-19 pandemic: A cross-sectional study |
title_full_unstemmed | Medication adherence among community-dwelling schizophrenia patients during the COVID-19 pandemic: A cross-sectional study |
title_short | Medication adherence among community-dwelling schizophrenia patients during the COVID-19 pandemic: A cross-sectional study |
title_sort | medication adherence among community-dwelling schizophrenia patients during the covid-19 pandemic: a cross-sectional study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461236/ https://www.ncbi.nlm.nih.gov/pubmed/36113253 http://dx.doi.org/10.1016/j.psychres.2022.114841 |
work_keys_str_mv | AT yaolansicheng medicationadherenceamongcommunitydwellingschizophreniapatientsduringthecovid19pandemicacrosssectionalstudy AT liuhongying medicationadherenceamongcommunitydwellingschizophreniapatientsduringthecovid19pandemicacrosssectionalstudy AT tianxiaobing medicationadherenceamongcommunitydwellingschizophreniapatientsduringthecovid19pandemicacrosssectionalstudy |